HRTS vs. YCS
HRTS (Tema Obesity & Cardiometabolic ETF) and YCS (ProShares UltraShort Yen) are both exchange-traded funds - HRTS is a Health & Biotech Equities fund actively managed by Tema, while YCS is a Leveraged Currency fund tracking the USD/JPY Exchange Rate (-200%). HRTS is actively managed, while YCS is passively managed. Over the past year, HRTS returned 20.97% vs 32.82% for YCS. At a correlation of -0.17, they often move in opposite directions. HRTS charges 0.75%/yr vs 1.00%/yr for YCS.
Performance
HRTS vs. YCS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRTS achieves a -5.70% return, which is significantly lower than YCS's 7.17% return.
HRTS
- 1D
- 0.51%
- 1M
- -0.90%
- YTD
- -5.70%
- 6M
- -5.48%
- 1Y
- 20.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
YCS
- 1D
- 0.17%
- 1M
- 4.42%
- YTD
- 7.17%
- 6M
- 10.05%
- 1Y
- 32.82%
- 3Y*
- 19.84%
- 5Y*
- 23.54%
- 10Y*
- 12.34%
HRTS vs. YCS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HRTS Tema Obesity & Cardiometabolic ETF | -5.70% | 23.93% | -4.30% | 14.97% |
YCS ProShares UltraShort Yen | 7.17% | 9.04% | 35.41% | -8.67% |
Correlation
The correlation between HRTS and YCS is -0.31, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.31 |
Correlation (All Time) Calculated using the full available price history since Nov 22, 2023 | -0.17 |
The correlation between HRTS and YCS shifts across timeframes, from -0.31 (1 year) to -0.17 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRTS vs. YCS — Risk / Return Rank
HRTS
YCS
HRTS vs. YCS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and ProShares UltraShort Yen (YCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HRTS | YCS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.61 | ||
| Sortino ratioReturn per unit of downside risk | -0.45 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.35 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.91 | 3.97 | -2.06 |
| Martin ratioReturn relative to average drawdown | 4.83 | 12.40 | -7.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HRTS | YCS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | 1.92 | -0.61 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.12 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.65 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.55 | 0.33 | +0.22 |
Drawdowns
HRTS vs. YCS - Drawdown Comparison
The maximum HRTS drawdown since its inception was -25.81%, smaller than the maximum YCS drawdown of -49.56%. Use the drawdown chart below to compare losses from any high point for HRTS and YCS.
Loading charts...
Drawdown Indicators
| HRTS | YCS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.81% | -49.56% | +23.75% |
Max Drawdown (1Y)Largest decline over 1 year | -11.01% | -8.30% | -2.71% |
Max Drawdown (3Y)Largest decline over 3 years | — | -23.05% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -27.32% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.32% | — |
Current DrawdownCurrent decline from peak | -9.14% | 0.00% | -9.14% |
Average DrawdownAverage peak-to-trough decline | -9.02% | -19.93% | +10.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.36% | 2.66% | +1.70% |
Volatility
HRTS vs. YCS - Volatility Comparison
Tema Obesity & Cardiometabolic ETF (HRTS) has a higher volatility of 4.44% compared to ProShares UltraShort Yen (YCS) at 2.75%. This indicates that HRTS's price experiences larger fluctuations and is considered to be riskier than YCS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HRTS | YCS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.44% | 2.75% | +1.69% |
Volatility (6M)Calculated over the trailing 6-month period | 11.26% | 12.32% | -1.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.03% | 17.27% | -1.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.07% | 21.10% | -2.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.07% | 19.01% | +0.06% |
HRTS vs. YCS - Expense Ratio Comparison
HRTS has a 0.75% expense ratio, which is lower than YCS's 1.00% expense ratio.
Dividends
HRTS vs. YCS - Dividend Comparison
HRTS's dividend yield for the trailing twelve months is around 1.42%, while YCS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
HRTS Tema Obesity & Cardiometabolic ETF | 1.42% | 1.34% | 1.63% |
YCS ProShares UltraShort Yen | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HRTS and YCS have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HRTS has higher volatility (4.44%) compared to YCS (2.75%). In terms of maximum drawdown, HRTS dropped -25.81% vs YCS's -49.56%.
On 1-year performance, YCS leads with 32.82% vs 20.97% for HRTS. On fees, HRTS is cheaper at 0.75% per year. On volatility, YCS has been the lower-risk option at 2.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, YCS has performed better with a 32.82% return vs 20.97%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HRTS is cheaper with a 0.75% expense ratio, compared with 1.00% for YCS.
HRTS has the higher dividend yield at 1.42%, compared with 0.00% for YCS.
HRTS is categorized as Health & Biotech Equities, while YCS is Leveraged Currency. They also come from different issuers: Tema and ProShares. Their fees differ too: 0.75% for HRTS and 1.00% for YCS.
YCS currently has the higher Sharpe Ratio (1.92 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HRTS and YCS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer